Preventing new-onset diabetes in thiazide-treated patients

The Lancet Diabetes and Endocrinology

Volumn 4, Issue 2, 2016, Pages 90-92

  Mancia, Giuseppe ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; CALCIUM CHANNEL BLOCKING AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; LOW DRUG DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OUTCOME ASSESSMENT; POTASSIUM DEPLETION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS; DIURETICS; HUMANS; HYPERTENSION; THIAZIDES;

EID: 84958053119     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00391-5     Document Type: Note

References (11)

1. Law MR, Wald NJ, Morris JK, Jordan RE Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003, 326:1427.
2. Mancia G, Fagard R, Narkiewicz K, et al. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens 2013, 31:1281-1357.
3. Mancia G, Grassi G, Zanchetti A New-onset diabetes and antihypertensive drugs. J Hypertens 2006, 24:3-10.
4. Elliott WJ, Meyer PM Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007, 369:201-207.
5. Dunder K, Lind L, Zethelius B, Berglund L, Lithell H Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study. BMJ 2003, 326:681.
6. Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 and 34 2011, National Clinical Guideline Centre, Royal College of Physicians (UK), London.
7. Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population. J Hypertens 2008, 26:1602-1611.
8. Bakris G, Molitch M, Hewkin A, et al. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome. Diabetes Care 2006, 29:2592-2597. for the STAR Investigators.
9. Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006, 48:219-224.
10. Brown MJ, Williams B, Morant S, et al. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial. Lancet Diabetes Endocrinol 2015, for the PATHWAY Studies Group, published online Oct 19. http://dx.doi.org/10.1016/S2213-8587(15)00377-0.
11. Stern MP, Williams K, Haffner SM Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?. Ann Intern Med 2002, 136:575-581.